The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Tumor, skin, and plasma concentrations of protein kinase inhibitors (PKIs) in patients with advanced cancer.
Mariette Labots
No relevant relationships to disclose
Maarten Neerincx
No relevant relationships to disclose
Johannes C. Van der Mijn
No relevant relationships to disclose
Henk Dekker
No relevant relationships to disclose
Richard Honeywell
No relevant relationships to disclose
Maria Rovithi
No relevant relationships to disclose
Kristy Gotink
No relevant relationships to disclose
Margreet Voebel-De Jong
No relevant relationships to disclose
Donald L. Van der Peet
No relevant relationships to disclose
Martijn R. Meijerink
No relevant relationships to disclose
Gerrit A. Meijer
No relevant relationships to disclose
Connie R. Jiménez
No relevant relationships to disclose
Godefridus J Peters
No relevant relationships to disclose
Henk M.W. Verheul
No relevant relationships to disclose